Activist investor Caligan picks up stake in ADMA, targets potential sale
Feb 4 (Reuters) - Activist investor Caligan Partners has bought a 5.6% stake in ADMA Biologics Inc and may urge the biotech company to consider a potential...
Feb 4 (Reuters) - Activist investor Caligan Partners has bought a 5.6% stake in ADMA Biologics Inc and may urge the biotech company to consider a potential...